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tions, we observed a decrease in IP7 
cellular concentrations in response to 
phosphate starvation (A.S., unpub-
lished data), suggesting that more 
characterization of this response may 
be necessary.
Lee et al. convincingly provide a 
link between Vip1-mediated inositol 
pyrophosphate signaling and phos-
phate metabolism. However, previous 
reports have also linked Kcs1 and its 
IP6K family members to phosphate 
metabolism, suggesting that both 
5PP-IP5 and 4/6PP-IP5 have roles in 
these processes. Indeed, the first clue 
to a relationship between inositol pyro-
phosphate signaling and phosphate 
metabolism came from the discovery 
that PiUS, a stimulator of inorganic 
phosphate uptake, was in fact IP6K2 
(Bennett et al., 2006). Then it was shown 
that inorganic phosphate uptake in 
yeast lacking Kcs1 is less efficient than 
in wild-type cells. Yeast lacking Kcs1 
also have increased expression of the 
PHO phosphate response genes and 
reduced intracellular polyphosphate 
levels (Auesukaree et al., 2005; Ben-
nett et al., 2006). Moreover, yeast lack-
ing Kcs1 constitutively express the acid 
phosphatase PHO5, which is activated 
by Pho4, indicating that the IP7 synthe-
sized by Kcs1 also influences the PHO 
transcriptional pathway (Auesukaree 
et al., 2005). These observations may 
reflect different aspects of IP7 function 
in phosphate sensing. It is possible that 
4/6PP-IP5 mainly regulates the PHO 
pathway by protein binding, whereas 
5PP-IP5 primarily functions as a phos-
phate donor.
The two new studies raise sev-
eral exciting possibilities that could 
advance our understanding of inosi-
tol pyrophosphates and their roles 
in many different aspects of cell sig-
naling. Certainly, the notion that two 
structurally different IP7 molecules 
can have distinct cellular roles is 
intriguing and will no doubt guide the 
way to more pioneering work. In the 
past decade, a large number of inosi-
tol pyrophosphate species, not only 
IP7 and IP8, have been discovered as 
well as several inositol pyrophosphate 
synthases and phosphatases. Further 
studies into these fascinating signaling 
molecules may result in the discovery 
of other species, perhaps even pyro-
phosphorylated inositol lipids.
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Retinoic acid—the active metabolite of vitamin A—influences biological processes 
by activating the retinoic acid receptor (RAR). In this issue, Schug et al. (2007) demon-
strate that retinoic acid also activates the peroxisome proliferator-activated receptor β/δ 
(PPARβ/δ). Remarkably, retinoic acid signaling through RAR or PPARβ/δ—which depends 
on cytoplasmic retinoic acid transporters—commits the cell to opposite fates, apoptosis 
or survival, respectively.The beneficial effects of vitamin A 
might have been recognized first by 
the ancient Egyptians, who treated 
eye disease with raw liver. The fact 
that they recognized a connection between eye problems and the liver, 
which is the richest source of dietary 
vitamin A, is astonishing. Today, we 
know that vitamin A (retinol) and its 
biologically active derivatives, the Cell 129retinoids (the most potent of which 
is all-trans-retinoic acid), regulate 
key processes such as inhibition 
of cell proliferation, differentiation, 
apoptosis, shaping of the embryo, , May 18, 2007 ©2007 Elsevier Inc. 649
and organogenesis. Vitamin 
A deficiency causes congeni-
tal malformations of the eye, 
heart, gonads, and lungs. 
In both youths and adults, 
lack of vitamin A impairs 
growth, vision, reproduction, 
and homeostasis of several 
organs (Mark et al., 2006). 
Active metabolites of vita-
min A can prevent and cure a 
majority of these defects. In 
addition, retinoids have anti-
cancer properties, as illus-
trated by their efficacy in the 
treatment of promyelocytic 
leukemia.
A long-standing question 
has been how a simple mole-
cule like all-trans-retinoic acid 
(RA) exerts pleiotropic actions. 
In an elegant study presented 
in this issue, Noy and col-
leagues (Schug et al., 2007) 
provide a new and unexpected 
answer to this question. These 
authors reveal that RA can sig-
nal through two nuclear hor-
mone receptors, the retinoic 
acid receptor (RAR) and the 
peroxisome proliferator-acti-
vated receptor β/δ (PPARβ/δ), 
leading to opposite outcomes 
for the cells expressing these recep-
tors: apoptosis and survival, respec-
tively (Figure 1).
To date, only one type of nuclear 
receptor, RAR (α, β, and γ), was 
thought to bind to both RA and 9-cis-
retinoic acid (Germain et al., 2006). 
RARs form heterodimers with retinoid 
X receptors (RXRs) α, β, or γ, which 
only bind to 9-cis-retinoic acid. RAR-
RXR heterodimers regulate gene 
expression through molecular mech-
anisms involving a large number of 
coregulators (Glass and Rosenfeld, 
2000). The interplay of these actors 
establishes a gradient of gene activ-
ity ranging from repression to full 
activation. As each component of 
this machinery is itself under specific 
transcriptional and posttranscrip-
tional control, a diversity of responses 
is possible.
During their transport in the aque-
ous intracellular milieu, many hydro-
phobic ligands including retinoids 
are solubilized and stabilized by 
binding to proteins that participate in 
mediating their biological activities. 
Two such proteins, CRABP-I and 
CRABP-II, have a high affinity for RA. 
CRABP-I is thought to dampen the 
cellular responses to RA by promot-
ing its degradation, whereas CRABP-
II delivers RA to RAR. This activity is 
mediated by a protein-protein inter-
action between CRABP-II and RAR, 
resulting in a direct transport of the 
ligand to the receptor (Dong et al., 
1999).
Both RA-binding proteins belong 
to an evolutionarily conserved family, 
which also includes nine fatty acid-
binding proteins (FABPs) (Chmurzyn-
ska, 2006). Some of the latter are 
known to deliver ligands to the PPARs. 
For instance, specific interactions 
with keratinocyte FABP (FABP5) and 
adipocyte FABP (FABP4) selectively 
enhance the activity of PPARβ/δ and 
PPARγ, respectively. Interestingly, 
these FABPs relocate to the 
nucleus when bound to lig-
ands that are selective for the 
PPAR isotype they activate. 
Thus, these FABPs control 
the transcriptional activities of 
their own ligands, which they 
transport to cognate PPARs in 
the nucleus (Tan et al., 2002). 
Interestingly, PPARs belong to 
the same type 2 class of recep-
tors as RARs in the nuclear 
receptor superfamily (Michalik 
et al., 2006). Together, these 
findings suggest a coevolution 
of the fatty-acid- and retin-
oid-binding protein families 
in parallel with the RAR and 
PPAR families, which enabled 
the emergence of a system 
for directing a ligand to the 
appropriate receptor. An inter-
esting question is whether 
the two associated systems, 
CRABPs-RAR and FABPs-
PPARs, have completely tight 
modes of action or if some 
promiscuity remains at the 
expense of specificity but in 
favor of an increased diversity 
in responses.
The work of Schug et al. 
(2007) provides a first answer 
to this interrogation. RA usually dis-
plays anticarcinogenic, proapoptotic 
activity. The authors were intrigued 
by an effect of RA in promoting cell 
survival in some organs, such as skin, 
in an RAR-independent manner (Cha-
pellier et al., 2002) and in a way that is 
reminiscent of PPARβ/δ activity (Di-Poi 
et al., 2002). They hypothesized that 
RA can control a repertoire of cellular 
responses that involves either RAR or 
PPARβ/δ. They found that—depend-
ing on the ratio of FABP5 to CRABP-
II—RA activates RAR or PPARβ/δ. In 
mammary carcinoma MCF-7 cells 
and in keratinocytes, which express 
a low and high FABP5 to CRABP-II 
ratio, respectively, RA activates RAR 
in the former and PPARβ/δ in the lat-
ter. Thus, the surprising finding is that 
when the FABP5 to CRABP-II ratio 
is high, RA serves as a physiologi-
cal ligand for PPARβ/δ. This directed 
transport of RA to PPARβ/δ broadens 
the spectrum of physiological regu-
figure 1. Retinoic Acid Activates RAR and PPARβ/δ
Vitamin A is internalized by the cell and metabolized into its 
active derivative, retinoic acid (RA). In the aqueous intracel-
lular milieu, RA is transported by the retinoid-binding pro-
tein CRABP-II, or by the fatty-acid-binding protein FABP5, 
depending on the ratio of FABP5 to CRABP-II. In a cell type 
expressing high CRABP-II and low FABP5, RA activates the 
retinoic acid receptor (RAR), whereas in the presence of the 
reverse ratio (low CRABP-II and high FABP5), RA activates 
the peroxisome proliferator-activated receptor β/δ (PPAR). 
This leads to opposite cellular outcomes: either apoptosis, 
growth arrest, and anticancer activity or survival, proliferation, 
and tumor growth, respectively. In both situations, retinoid X 
receptor (RXR) is the indispensable dimerization partner of the 
nuclear receptor involved.650 Cell 129, May 18, 2007 ©2007 Elsevier Inc.
lation of the receptor’s activity in an 
unexpected way, and it sheds new 
light on RA as an antiapoptotic agent 
and on PPARβ/δ as an RA receptor. 
This raises numerous new questions. 
Does RA exert antiapoptotic, propro-
liferative effects in tumors other than 
the mammary cancer model used by 
Schug et al. (2007)? Are some devel-
opmental processes, which are con-
trolled by RA, dependent on directed 
transport of RA to PPARβ/δ? Can the 
switch from proliferation to differentia-
tion observed in organ development 
be a consequence of ligand prefer-
ence for one receptor over the other? 
PPARβ/δ, in addition to cell-survival 
functions, also participates in meta-
bolic regulation under the control of 
fatty-acid ligands. Does RA partici-
pate in these regulations under spe-
cific conditions?The packaging of chromosomal DNA 
into heterochromatin is important for 
cellular processes such as regula-
tion of gene expression and accurate 
chromosome segregation. In the fis-
sion yeast, Schizosaccharomyces 
pombe, heterochromatin is found at 
the mating-type locus, telomeres, 
and centromeres. Regions of hetero-
chromatin are generally associated 
with transcriptional repression, and 
consistent with this finding, marker 
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In fission yeast, RNA interfe
transgenes inserted at centro
RNAi machinery directly targ
silencing to a protein comple
promotes transcript degrada
degradation may also contribIn fact, the key issue raised by the 
work of Schug et al. (2007) concerns 
the importance of directed ligand 
transport in nuclear receptor activa-
tion and ligand-dependent crosstalk 
between different receptor types. 
Breaking barriers between receptor 
categories by this mechanism may 
not be unique to RAR and PPARβ/δ. 
Promiscuity induced by directed lig-
and transport may participate signifi-
cantly in the astonishing pleiotropic 
effects of key members of the nuclear 
receptor superfamily.
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tromere transcripts are required to tar-
get chromatin-modifying machinery 
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